UndisclosedMergerHealthcare & Life SciencesCompleted
Lanterne Dx merges with Flagship Biosciences
CRO Lanterne Dx completed its merger with Ampersand-backed digital pathology firm Flagship Biosciences; the combined company keeps the Lanterne Dx name under CEO Jon Bishop.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following healthcare M&A?
The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.
See what you get →